Christine A. Mundkur

Christine A. Mundkur became a director at Cardinal Health in 2022 and has also served on the Board of Directors at MannKind Corporation since 2018. Ms. Mundkur served on the Board of Directors at Lupin Limited from 2019 to 2022 and was the Chief Executive Officer and non-voting Chair of the Board at Impopharma, Inc. from 2013 to 2017. From 2011 to 2013, Ms. Mundkur served as the President of CM Strategic Advisors. Prior to 2013, Ms. Mundkur worked at Sandoz, Inc as the President and Chief Executive Officer of the U.S. Division and Head of Commercial operations in North America from 2009 to 2010 and was the Chief Executive Officer of Barr Laboratories in 2008.